A safety and efficacy study of a one-time intravitreal injection of SAR446597 in participants with geographic atrophy secondary to age-related macular degeneration

Trial Identifier: DFI18231
Sponsor: Sanofi
Start Date: October 2025
Primary Completion Date: October 2027
Study Completion Date: July 2032
Condition: Eye Conditions

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
UNITED STATES, Arizona Peoria, Arizona, UNITED STATES, 85381
UNITED STATES, Arizona Scottsdale, Arizona, UNITED STATES, 85255
UNITED STATES, Florida Gainesville, Florida, UNITED STATES, 32607
UNITED STATES, Florida St. Petersburg, Florida, UNITED STATES, 33711
UNITED STATES, Illinois Lemont, Illinois, UNITED STATES, 60439
UNITED STATES, Maryland Chevy Chase, Maryland, UNITED STATES, 20815
UNITED STATES, Maryland Hagerstown, Maryland, UNITED STATES, 21740
UNITED STATES, Oregon Eugene, Oregon, UNITED STATES, 97401
UNITED STATES, Pennsylvania Bethlehem, Pennsylvania, UNITED STATES, 18017-9412
UNITED STATES, Texas Austin, Texas, UNITED STATES, 78750
UNITED STATES, Texas Dallas, Texas, UNITED STATES, 75231
UNITED STATES, Texas San Antonio, Texas, UNITED STATES, 78240